-
A new UN report calls for enhanced due diligence processes to tackle ABC and AML-related risks and strengthened ESG commitments. -
Doing business with State Owned Enterprises (SOEs) exposes organisations to elevated risk. See why enhanced due diligence is a must when dealing with SOEs -
The case is a stark reminder of the reputational, regulatory, financial and strategic costs when a compliance programme falls short. -
Today, pharmaceutical companies face tougher expectations than ever, both from their shareholders and from consumers. Recent FCPA settlements suggest the pharma industry still has a number of unresolved risk issues to solve. Take a closer look on our blog. -
2020 is a key year for legislation against Money Laundering, with the EU’s 5th and 6th AML Directives coming into force. See what that means for your company, and how to effectively manage AML risk
